Overview

SGLT2 Inhibition: Uric Acid Excretion Study

Status:
Completed
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The current study investigates the effects of SGLT2 inhibitor empagliflozin on uric acid excretion.
Phase:
Phase 4
Details
Lead Sponsor:
VU University Medical Center
Treatments:
Benzbromarone
Empagliflozin